Navigation Links
Humeral Fracture Orthosis (over-the-shoulder)

ProductsHumeral Fracture Orthosis (over-the-shoulder)
Company Sky Medical, Inc.
Item Humeral Fracture Orthosis (over-the-shoulder)
Features 
  • Adjustable for volumetric changes during healing
  • Hook and loop straps maintain soft tissue compression
  • Neutral design fits left or right
    • Description This comfortable pre-fabricated orthosis is designed for the management of mid-shaft to distal third humeral diaphyseal fractures. The lightweight anatomical design achieves total contact circumferential soft tissue compression for optimal control of humeral segments while allowing range-of- motion of both shoulder and elbow joints. In addition this brace features a deltoid cap extension which provides greater alignment control and prevents distal slippage. Two double thickness cotton stockinette are provided.
    Info Sky Medical, Inc.
    Customer Service: (888) 769-6084
    Web site: http://www.skymedicalinc.com

    Related medicine products :

    1. Uniflex Humeral Nail System
    2. AIM Titanium Humeral Nail System
    3. Retrograde® Humeral Nail System
    4. T2™ Humeral Nailing System
    5. Extended Length Humeral Splint
    6. Humeral Splint
    7. Humeral Fracture Orthosis (standard cuff model)
    8. Humeral Stabilizing System (HSS)
    9. Boies Nasal Fracture Elevator
    10. Exogen 2000+, or Sonic Accelerated Fracture Healing System (SAFHS)
    11. Amsco OrthoVision Orthopedic and Fracture Table
    Breaking Medicine News(10 mins):Health News:Blood Thinner Combos Risky for Heart Attack Patients 2Health News:Centegra Expands H1N1 Vaccines to General Public 2Health News:Centegra Expands H1N1 Vaccines to General Public 3Health News:Centegra Expands H1N1 Vaccines to General Public 4Health News:Do Charitable Gift Donations Make a Difference? 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 2Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 3Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 4Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 5Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 6
    Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 1Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 2Indiana Home Health Agency Pays Nearly 242 Million to Settle False Claims Act Allegations 59819 1Hologic to Present at Citis 2009 Sixth Annual Small Mid Cap Conference 5609 1